scispace - formally typeset
R

Ruggero De Maria

Researcher at Catholic University of the Sacred Heart

Publications -  231
Citations -  23673

Ruggero De Maria is an academic researcher from Catholic University of the Sacred Heart. The author has contributed to research in topics: Cancer stem cell & Cancer. The author has an hindex of 53, co-authored 215 publications receiving 18933 citations. Previous affiliations of Ruggero De Maria include Thomas Jefferson University & Sapienza University of Rome.

Papers
More filters
Journal ArticleDOI

Identification and expansion of human colon-cancer-initiating cells

TL;DR: It is concluded that colorectal cancer is created and propagated by a small number of undifferentiated tumorigenic CD133+ cells, which should therefore be the target of future therapies.
Journal ArticleDOI

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

Lorenzo Galluzzi, +186 more
TL;DR: The Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for the definition and interpretation of cell death from morphological, biochemical, and functional perspectives.
Journal ArticleDOI

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells

TL;DR: A variable number (range 20–90%, mean 60.7%) of endothelial cells in glioblastoma carry the same genomic alteration as tumour cells, indicating that a significant portion of the vascular endothelium has a neoplastic origin.
Journal Article

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

Lorenzo Galluzzi, +168 more
- 01 Jan 2018 - 
TL;DR: An updated classification of cell death subroutines focusing on mechanistic and essential aspects of the process is proposed, and the utility of neologisms that refer to highly specialized instances of these processes are discussed.
Journal ArticleDOI

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities.

TL;DR: It is proposed thatmiR-15a and miR-16 act as tumor suppressor genes in prostate cancer through the control of cell survival, proliferation and invasion through the regulation of BCL2 and CCND1.